PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Family Medicine and Population Health (FAMPOP), University of Antwerp, Antwerpen, Belgium niels.adriaenssens@uantwerpen.be.\', \'Département des Sciences Cliniques, University of Liege, Liege, Belgium.\', \'Interuniversity Institute for Biostatistics and Statistical Bioinformatics (I-BioStat), Data Science Institute, Hasselt University, Hasselt, Belgium.\', \'Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerpen, Belgium.\', \'Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium.\', \'Nuffield Department of Primary Care Health Sciences, Oxford University, Oxford, UK.\', \'Department of Public Health and Primary Care, Ghent University, Gent, Belgium.\', \'Department of Infectious Diseases in Humans, Sciensano, Brussel, Belgium.\', \'Centre for the Evaluation of Vaccination, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerpen, Belgium.\', \'Department of Epidemiology and Public Health, Sciensano, Brussel, Belgium.\', \'Department of Family Medicine and Population Health (FAMPOP), University of Antwerp, Antwerpen, Belgium.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1136/bmjopen-2021-054688
?:hasPublicationType
?:journal
  • BMJ open
is ?:pmid of
?:pmid
?:pmid
  • 35105642
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.372
?:rankingScore_hIndex
  • 57
is ?:relation_isRelatedTo_publication of
?:title
  • Prevalence and incidence of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium during 1 year of the COVID-19 epidemic: prospective cohort study protocol.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all